STOCK TITAN

Centerspace Form 4 Filings

CSR NYSE

Every Form 4 that Centerspace (CSR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CSR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CSR filings page.

Rhea-AI Summary

CENTERSPACE director Rodney Jones-Tyson made an open-market purchase of 1,700 Common Shares of Beneficial Interest on June 22, 2026 at an average price of $55.26 per share. Following this buy, he directly holds 7,877 common shares, indicating a modest increase in his personal stake.

Rhea-AI Summary

CENTERSPACE director John A. Schissel reported an open-market purchase of company stock. On June 18, 2026, he bought 500 Common Shares of Beneficial Interest at a price of $54.90 per share. Following this transaction, he directly owns 17,195 common shares of Centerspace.

Rhea-AI Summary

Centerspace director Emily Nagle Green reported an equity compensation-related transaction involving restricted stock units. On 2026-06-01, she exercised 1,446 restricted stock units at $0.00 per unit, receiving 1,446 common shares of beneficial interest. After this exercise, she directly holds 8,568 common shares. The filing also notes an additional 454.198 common shares held indirectly through her spouse, and a footnote explains that 16 of the reported shares were acquired under Centerspace’s dividend reinvestment program.

Rhea-AI Summary

Centerspace director John A. Schissel exercised restricted stock units into common shares. On June 1, 2026, he converted 2,297 restricted stock units into 2,297 Common Shares of Beneficial Interest at an exercise price of $0 per share. After this transaction, he directly holds 16,695 common shares and no remaining restricted stock units.

Rhea-AI Summary

Centerspace director Mary J. Twinem exercised restricted stock units into common shares. On 2026-06-01, 1,446 restricted stock units converted into 1,446 Common Shares of Beneficial Interest at a stated price of $0.00 per share, reflecting equity compensation rather than an open‑market purchase.

After this derivative exercise, Twinem directly holds 11,566 common shares. The related restricted stock unit award is now fully settled, with no remaining derivative position reported in this filing.

Rhea-AI Summary

Centerspace director Jay L. Rosenberg exercised 1,446 restricted stock units into common shares of beneficial interest. These RSUs converted on a one-for-one basis into common shares at no cash exercise price. Following the transaction, he directly holds 2,587 common shares of beneficial interest.

Rhea-AI Summary

Centerspace director Rodney Jones-Tyson exercised equity awards, increasing his direct shareholdings. On June 1, 2026, 1,446 Restricted Stock Units converted into 1,446 Common Shares of Beneficial Interest at a stated price of $0.00 per unit.

Following this derivative exercise, Jones-Tyson directly holds 6,177 Common Shares of Beneficial Interest. The transaction reflects routine equity compensation vesting rather than an open‑market purchase or sale, and no remaining Restricted Stock Units are shown after this conversion.

Rhea-AI Summary

Centerspace director Hixon Ola Oyinsan reported an exercise of equity awards that converted 1,446 Restricted Stock Units into an equal number of Common Shares of Beneficial Interest. These RSUs represented a contingent right to receive one common share each when they vested.

Following this non-cash derivative exercise, Oyinsan now directly holds 3,193 Common Shares of Beneficial Interest. The filing shows an exercise and conversion of RSUs rather than an open-market purchase or sale of Centerspace shares.

Rhea-AI Summary

Schissel John A reported acquisition or exercise transactions in this Form 4 filing.

Centerspace director John A. Schissel received a grant of 2,124 restricted stock units (RSUs). These RSUs represent a contingent right to receive an equal number of Centerspace common shares of beneficial interest, vesting on May 13, 2027. After this compensation-related award, Schissel’s directly held RSU balance reported in this filing is 2,124 units.

Rhea-AI Summary

CENTERSPACE director Ola Oyinsan received a grant of 1,337 restricted stock units (RSUs) on May 13, 2026. These RSUs are a contingent right to receive an equal number of common shares of beneficial interest, scheduled to vest on May 13, 2027.

Following this compensation-related award, Oyinsan is reported as holding 1,337 RSUs directly, with no exercise price and no open‑market buying or selling involved. The award reflects standard equity-based director compensation rather than a discretionary market transaction.

Rhea-AI Summary

Jones-Tyson Rodney reported acquisition or exercise transactions in this Form 4 filing.

Centerspace director Rodney Jones-Tyson received a grant of 1,337 restricted stock units. These RSUs represent a contingent right to receive 1,337 common shares of beneficial interest, with no cash paid per unit. The award vests on May 13, 2027, and results in 1,337 derivative shares reported as directly owned.

Rhea-AI Summary

Centerspace director Jay L. Rosenberg received a grant of 1,337 restricted stock units (RSUs). These RSUs represent a contingent right to receive an equal number of Centerspace common shares of beneficial interest, vesting on May 13, 2027. The grant is compensation-related, with no cash paid by Rosenberg and no open-market buying or selling involved. Following this award, his reported RSU holdings from this grant total 1,337 units, which will convert into common shares only if the vesting conditions are satisfied.

Rhea-AI Summary

Centerspace reported that director Mary J. Twinem received a grant of 1,337 restricted stock units (RSUs). These RSUs represent a contingent right to receive an equal number of common shares of beneficial interest, vesting on May 13, 2027.

The award was granted at an exercise price of $0.00 per unit as part of equity compensation, and following this grant Twinem holds 1,337 RSUs directly. This is a routine compensation-related acquisition rather than an open-market purchase or sale.

Rhea-AI Summary

Centerspace EVP and CFO Bhairav Patel exercised 1,831 Restricted Stock Units into an equal number of Common Shares of Beneficial Interest on March 31, 2026. To cover taxes on the vesting, 637 common shares were withheld at $57.45 per share rather than sold in the open market.

After these compensation-related transactions, Patel directly holds 9,062 common shares. The filing reflects routine equity vesting and associated tax withholding rather than discretionary open-market buying or selling.

Rhea-AI Summary

Centerspace President and CEO Anne Olson exercised 5,492 restricted stock units into common shares. These RSUs converted into 5,492 Common Shares of Beneficial Interest at a stated price of $0.00 per share. Of these, 2,875 shares were withheld at $57.45 per share to cover tax obligations in connection with the vesting. After the transactions, Olson directly holds 30,226 common shares, reflecting a net increase in her equity position and no open derivative position from these RSUs.

Rhea-AI Summary

Centerspace executive vice president and CFO Bhairav Patel reported equity compensation activity in the company’s common shares of beneficial interest. On February 2, 2026, he acquired 620 shares at $0 upon vesting of a performance share award tied to total shareholder return versus the FTSE Nareit Equity Index.

The award, originally granted on January 1, 2023, paid out at 183.20% of target, or 5,444 shares, after the company’s estimated return reached the 70.8 percentile of the benchmark over the 2023–2025 measurement period. Of this, 4,824 shares were issued on December 26, 2025 and the remaining 620 on February 2, 2026.

Also on February 2, 2026, 202 shares were withheld at a price of $63.83 to cover taxes related to the vesting. After these transactions, Patel directly owned 7,868 Centerspace shares.

Rhea-AI Summary

Centerspace President, CEO & Secretary Anne Olson reported equity transactions tied to a performance share award. On February 2, 2026, she received 1,050 common shares of beneficial interest at $0 as the final 10% of a 2023–2025 TSR-based performance award, bringing total payout to 9,227 shares. For this award, the Company’s estimated total shareholder return ranked at the 70.8 percentile versus the FTSE Nareit Equity Index, resulting in a 183.20% of target payout. Also on February 2, 322 shares were withheld at a price of $63.83 per share to cover taxes on vesting. After these transactions, Olson directly owned 27,609 Centerspace common shares of beneficial interest.

Rhea-AI Summary

Centerspace executive reports new equity award. A Form 4 filing for Centerspace (CSR) discloses that an officer serving as EVP and CFO received a grant of 4,895 restricted stock units. The award has a conversion price of $0 per unit and relates to common shares of beneficial interest. According to the filing, this represents a time-based contingent right to receive 4,895 common shares, vesting over three years in one-third increments on each anniversary of the grant date on January 1, 2027, 2028 and 2029. Following this transaction, the reporting person beneficially owns 4,895 derivative securities directly.

Rhea-AI Summary

Centerspace reported an equity award to its President, CEO and Secretary, Anne Olson, in the form of restricted stock units. On 01/01/2026, she acquired 13,437 restricted stock units at an exercise price of $0, each tied to a future issuance of one common share of beneficial interest.

The award is time-based and vests in three equal annual installments. One third of the 13,437 units is scheduled to vest on each anniversary of the grant date, specifically on January 1, 2027, 2028 and 2029. The units are reported as directly owned derivative securities and are a form of stock-based compensation rather than an open-market purchase.

Rhea-AI Summary

Centerspace President, CEO and Secretary Anne Olson reported several equity award transactions dated December 26, 2025. Restricted stock units covering 1,008, 3,378, and 2,938 common shares of beneficial interest were exercised at $0 per share as their vesting was accelerated from January 1, 2026 to December 26, 2025.

Olson also received 8,177 common shares from a performance share award granted January 1, 2023, based on the company’s total shareholder return versus the FTSE Nareit Equity Index, which paid out at 180.4% of target after the company’s estimated TSR reached the 70th percentile. To cover taxes on these vestings, 3,835 and 4,281 shares were withheld at $67.21 per share. After these transactions, Olson directly owned 26,881 Centerspace common shares.

Rhea-AI Summary

Centerspace executive Bhairav Patel reported multiple equity award transactions on December 26, 2025. The EVP and CFO acquired common shares of beneficial interest through the vesting and exercise of restricted stock units and a performance share award, with several grants exercised at an exercise price of $0. After these transactions, he held 7,450 common shares directly.

The filing notes that certain restricted stock units scheduled to vest on January 1, 2026 were accelerated to December 26, 2025. A performance share award granted on January 1, 2023, tied to total shareholder return versus the FTSE Nareit Equity Index, was also largely accelerated, resulting in 4,824 shares being issued based on an estimated payout of 180.4% of target. Shares totaling 1,427 and 2,468 were withheld at $67.21 per share to cover taxes on the vesting events.